TechCrunch
SEPTEMBER 9, 2021
Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech.
TechCrunch
DECEMBER 20, 2021
GHI Fund President Bill Taranto has spent more than two decades in the healthcare industry and has 15 years of experience in healthcare investing. In addition to his venture investing knowledge, Bill has decades of management operations experience. 4 strategies for building a digital health unicorn. Share on Twitter.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch
APRIL 6, 2022
As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. So how do we pick which companies to invest in? Share on Twitter.
TechCrunch
MAY 12, 2023
is discussed,” said Amy Kruse, chief investment officer, Satori Neuro. Like several investors we surveyed, Kruse doesn’t solely invest in psychedelics, but they are very much on her radar. But that’s not to say the path to commercialization and wider adoption is closed to psychedelic startups and investors at the moment.
TechCrunch
FEBRUARY 10, 2022
Atommerce , a Korean startup that helps users connect with mental health professionals via a mobile app MiNDCAFE, plans to scale its mental health service with a $16.7 The Seoul-based startup offers a virtual therapy program and a mental health benefits solution for employers.
TechCrunch
NOVEMBER 3, 2021
As the world’s population ages, more is being learned about brain health as startups leverage technology to find a way to slow down cognitive impairment. This startup just raised $8 million to help busy doctors assess the cognitive health of 50 million seniors.
TechCrunch
MARCH 14, 2022
startup that offers personalized digital therapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Vira Health , a U.K. based VC firm Optum Ventures, as it gears up to hop over the pond.
Expert insights. Personalized for you.
93 
Let's personalize your content